Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining

被引:13
作者
Luo, Jiao [1 ]
Zhang, Wang [1 ]
Su, Cailing [1 ]
Zhou, Zhanmei [1 ]
Wang, Guobao [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Renal Div,State Key Lab Organ Failure Res, Guangzhou, Peoples R China
关键词
PLA2R antibody; PLA2R antigen; PLA2R-associated MN; renal pathologic chronicity lesions; PHOSPHOLIPASE-A2 RECEPTOR AUTOANTIBODIES; ANTI-PLA(2)R AUTOANTIBODIES; GLOMERULAR DEPOSITS; KIDNEY BIOPSY; ANTIBODIES; DIAGNOSIS; ANTIGEN;
D O I
10.1093/ndt/gfaa239
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Serum phospholipase A2 receptor (PLA2R) anti-body (SAb) and glomerular deposits of PLA2R antigen (GAg) have been tested widely in idiopathic membranous nephropathy (MN). Recently, we noticed a special form of PLA2R-associated MN with positive circulating PLA2R antibody but negative PLA2R deposits in the glomeruli by immunofluorescence on frozen tissue (IF-F). The significance of this form of PLA2R-associated MN is yet to be elucidated. This study aimed to explore the clinicopathological features of these PLA2R-associated MN patients. Methods. This study enrolled 229 biopsy-proven PLA2R-associated MN patients with SAb+. SAb was measured by enzyme-linked immunosorbent assay, and GAg was detected by IF-F. These patients were divided into SAb+/GAg+ and SAb+/GAg- groups. Clinicopathological characteristics of SAb+/GAg+ and SAb+/GAg- PLA2R-associated MN patients were compared. PLA2R antigens of 19 SAb+/GAg- PLA2R-associated MN patients were verified by immunohistochemistry on paraffin tissue (IHC-P). Results. Among 229 SAb+ PLA2R-associated MN patients, 210 (91.70%) were GAg+ and 19 (8.3%) were GAg-. These 19 SAb+/GAg- PLA2R-associated MN patients presented positive PLA2R deposits by IHC-P. Compared with SAb+/GAg+ PLA2R-associated MN patients, SAb+/GAg- PLA2R-associated MN patients had higher levels of serum PLA2R anti-body (P = 0.004), increased proteinuria (P = 0.008), lower serum albumin (P = 0.019), more prominent chronic pathological lesions in terms of glomerulosclerosis score (P = 0.025), interstitial fibrosis score (P = 0.016), tubular atrophy score (P = 0.010) and total renal chronicity score (P = 0.010), and were more likely to be accompanied by focal segmental glomerulosclerosis (P = 0.014). Higher SAb level was associated with the total renal chronicity score (odds ratio per 100 RU/mL, 1.16; 95% confidence interval 1.01-1.33; P = 0.033). Conclusions. PLA2R-associated MN patients with seropositive PLA2R antibody but negative PLA2R deposits in the glomeruli by IF-F have higher levels of SAb and worse clinicopathological manifestations compared with their double-positive counterparts. IHC-P can be an alternative technique to reveal PLA2R glomerular deposits.
引用
收藏
页码:2216 / 2223
页数:8
相关论文
共 50 条
[31]   Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy [J].
Li, Xin ;
Wei, Dong ;
Zhou, Zhanmei ;
Wang, Baoguo ;
Xu, Ya ;
Pan, Jie ;
Yang, Chunli ;
Lu, Jie ;
Qiu, Yurong .
MEDICAL SCIENCE MONITOR, 2016, 22
[32]   HLA Alleles and Prognosis of PLA2R-Related Membranous Nephropathy [J].
Le, Wei-Bo ;
Shi, Jing-Song ;
Fan, Yang ;
Gong, Si-Wen .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (08) :1221-1227
[33]   Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings [J].
Kaya, Bulent ;
Paydas, Saime ;
Balal, Mustafa ;
Eren Erdogan, Kivilcim ;
Gonlusen, Gulfiliz .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
[34]   Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy : A Single-Center Study from China [J].
Pan, Yan ;
Chen, Wei Dong ;
Liu, Lei ;
Yang, Huijuan ;
Chang, Baochao ;
Cui, Caixia .
IMMUNOTARGETS AND THERAPY, 2024, 13 :385-398
[35]   Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy [J].
Wang, Yu ;
He, Yi-Xin ;
Diao, Tian-Tian ;
Wei, Shi-Yao ;
Qi, Wen-Rui ;
Wang, Cen-Cen ;
Song, Shu-Min ;
Bi, Min ;
Li, Chun-Mei ;
Zhang, Cai-Xia ;
Hou, Yan-Pei ;
Wei, Qiu-Ju ;
Li, Bing .
ONCOTARGET, 2018, 9 (01) :67-74
[36]   Role of PLA2R domain antibodies and epitope spreading in risk stratification and prediction of proteinuria remission in primary membranous nephropathy [J].
Zhang, Xiran ;
Yang, Feiya ;
Fan, Yun ;
Xue, Jing ;
Liu, Bin ;
Zhang, Zhijian ;
Shan, Weiwei ;
Chen, Hanzhi ;
Cai, Ting ;
Zhou, Leting ;
Huang, Biao ;
Wang, Liang ;
Liu, Xiaobin .
SCIENTIFIC REPORTS, 2025, 15 (01)
[37]   Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy [J].
Berchtold, Lena ;
Zanetta, Gilbert ;
Dahan, Karine ;
Mihout, Fabrice ;
Peltier, Julie ;
Guerrot, Dominique ;
Brocheriou, Isabelle ;
Ronco, Pierre ;
Debiec, Hanna .
KIDNEY INTERNATIONAL REPORTS, 2018, 3 (02) :486-491
[38]   Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era [J].
Safar-Boueri, Luisa ;
Piya, Albina ;
Beck, Laurence H., Jr. ;
Ayalon, Rivka .
PEDIATRIC NEPHROLOGY, 2021, 36 (01) :19-30
[39]   PLA2R-positive (primary) membranous nephropathy in a child with IPEX syndrome [J].
Chuva, Teresa ;
Pfister, Frederick ;
Beringer, Ortraud ;
Felgentreff, Kerstin ;
Buettner-Herold, Maike ;
Amann, Kerstin .
PEDIATRIC NEPHROLOGY, 2017, 32 (09) :1621-1624
[40]   Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy [J].
Van de Logt, Anne-Els ;
Justino, Joana ;
Vink, Coralien H. ;
van den Brand, Jan ;
Debiec, Hanna ;
Lambeau, Gerard ;
Wetzels, Jack F. .
KIDNEY INTERNATIONAL REPORTS, 2021, 6 (06) :1677-1686